TTF1 and non-small cell lung carcinoma: Additionally, nonsquamous NSCLC patients with negative TTF‐1 expression treated with docetaxel, another standard cytotoxic agent for NSCLC, showed a lower disease control rate and shorter OS than their counterparts with positive TTF‐1 expression.17